Global Ertapenem Injection Market Growth 2025-2031

October 2025 | 83 pages | ID: G317C084C79EN
LP Information

Abstracts

The global Ertapenem Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.

United States market for Ertapenem Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Ertapenem Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Ertapenem Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Ertapenem Injection players cover Merck, Endo, Aurobindo Pharma, ACS Dobfar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Ertapenem Injection Industry Forecast? looks at past sales and reviews total world Ertapenem Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Ertapenem Injection sales for 2025 through 2031. With Ertapenem Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ertapenem Injection industry.

This Insight Report provides a comprehensive analysis of the global Ertapenem Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ertapenem Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ertapenem Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ertapenem Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ertapenem Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 1g/Vial
• Others

Segmentation by Application:

• Adult
• Pediatric

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Endo
• Aurobindo Pharma
• ACS Dobfar

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ertapenem Injection market?
What factors are driving Ertapenem Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ertapenem Injection market opportunities vary by end market size?
How does Ertapenem Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ertapenem Injection Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Ertapenem Injection by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Ertapenem Injection by Country/Region, 2020, 2024 & 2031
2.2 Ertapenem Injection Segment by Type
  2.2.1 1g/Vial
  2.2.2 Others
2.3 Ertapenem Injection Sales by Type
  2.3.1 Global Ertapenem Injection Sales Market Share by Type (2020-2025)
  2.3.2 Global Ertapenem Injection Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Ertapenem Injection Sale Price by Type (2020-2025)
2.4 Ertapenem Injection Segment by Application
  2.4.1 Adult
  2.4.2 Pediatric
2.5 Ertapenem Injection Sales by Application
  2.5.1 Global Ertapenem Injection Sale Market Share by Application (2020-2025)
  2.5.2 Global Ertapenem Injection Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Ertapenem Injection Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Ertapenem Injection Breakdown Data by Company
  3.1.1 Global Ertapenem Injection Annual Sales by Company (2020-2025)
  3.1.2 Global Ertapenem Injection Sales Market Share by Company (2020-2025)
3.2 Global Ertapenem Injection Annual Revenue by Company (2020-2025)
  3.2.1 Global Ertapenem Injection Revenue by Company (2020-2025)
  3.2.2 Global Ertapenem Injection Revenue Market Share by Company (2020-2025)
3.3 Global Ertapenem Injection Sale Price by Company
3.4 Key Manufacturers Ertapenem Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ertapenem Injection Product Location Distribution
  3.4.2 Players Ertapenem Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ERTAPENEM INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Ertapenem Injection Market Size by Geographic Region (2020-2025)
  4.1.1 Global Ertapenem Injection Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Ertapenem Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ertapenem Injection Market Size by Country/Region (2020-2025)
  4.2.1 Global Ertapenem Injection Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Ertapenem Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ertapenem Injection Sales Growth
4.4 APAC Ertapenem Injection Sales Growth
4.5 Europe Ertapenem Injection Sales Growth
4.6 Middle East & Africa Ertapenem Injection Sales Growth

5 AMERICAS

5.1 Americas Ertapenem Injection Sales by Country
  5.1.1 Americas Ertapenem Injection Sales by Country (2020-2025)
  5.1.2 Americas Ertapenem Injection Revenue by Country (2020-2025)
5.2 Americas Ertapenem Injection Sales by Type (2020-2025)
5.3 Americas Ertapenem Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ertapenem Injection Sales by Region
  6.1.1 APAC Ertapenem Injection Sales by Region (2020-2025)
  6.1.2 APAC Ertapenem Injection Revenue by Region (2020-2025)
6.2 APAC Ertapenem Injection Sales by Type (2020-2025)
6.3 APAC Ertapenem Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ertapenem Injection by Country
  7.1.1 Europe Ertapenem Injection Sales by Country (2020-2025)
  7.1.2 Europe Ertapenem Injection Revenue by Country (2020-2025)
7.2 Europe Ertapenem Injection Sales by Type (2020-2025)
7.3 Europe Ertapenem Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ertapenem Injection by Country
  8.1.1 Middle East & Africa Ertapenem Injection Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Ertapenem Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Ertapenem Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Ertapenem Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ertapenem Injection
10.3 Manufacturing Process Analysis of Ertapenem Injection
10.4 Industry Chain Structure of Ertapenem Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ertapenem Injection Distributors
11.3 Ertapenem Injection Customer

12 WORLD FORECAST REVIEW FOR ERTAPENEM INJECTION BY GEOGRAPHIC REGION

12.1 Global Ertapenem Injection Market Size Forecast by Region
  12.1.1 Global Ertapenem Injection Forecast by Region (2026-2031)
  12.1.2 Global Ertapenem Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ertapenem Injection Forecast by Type (2026-2031)
12.7 Global Ertapenem Injection Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Ertapenem Injection Product Portfolios and Specifications
  13.1.3 Merck Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Endo
  13.2.1 Endo Company Information
  13.2.2 Endo Ertapenem Injection Product Portfolios and Specifications
  13.2.3 Endo Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Endo Main Business Overview
  13.2.5 Endo Latest Developments
13.3 Aurobindo Pharma
  13.3.1 Aurobindo Pharma Company Information
  13.3.2 Aurobindo Pharma Ertapenem Injection Product Portfolios and Specifications
  13.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Aurobindo Pharma Main Business Overview
  13.3.5 Aurobindo Pharma Latest Developments
13.4 ACS Dobfar
  13.4.1 ACS Dobfar Company Information
  13.4.2 ACS Dobfar Ertapenem Injection Product Portfolios and Specifications
  13.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 ACS Dobfar Main Business Overview
  13.4.5 ACS Dobfar Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ertapenem Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Ertapenem Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1g/Vial
Table 4. Major Players of Others
Table 5. Global Ertapenem Injection Sales by Type (2020-2025) & (K Units)
Table 6. Global Ertapenem Injection Sales Market Share by Type (2020-2025)
Table 7. Global Ertapenem Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Ertapenem Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Ertapenem Injection Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Ertapenem Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Ertapenem Injection Sale Market Share by Application (2020-2025)
Table 12. Global Ertapenem Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Ertapenem Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Ertapenem Injection Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Ertapenem Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Ertapenem Injection Sales Market Share by Company (2020-2025)
Table 17. Global Ertapenem Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Ertapenem Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Ertapenem Injection Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Ertapenem Injection Producing Area Distribution and Sales Area
Table 21. Players Ertapenem Injection Products Offered
Table 22. Ertapenem Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ertapenem Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Ertapenem Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Ertapenem Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Ertapenem Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Ertapenem Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Ertapenem Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Ertapenem Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Ertapenem Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Ertapenem Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Ertapenem Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Ertapenem Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Ertapenem Injection Sales by Type (2020-2025) & (K Units)
Table 37. Americas Ertapenem Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Ertapenem Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Ertapenem Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Ertapenem Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Ertapenem Injection Sales by Type (2020-2025) & (K Units)
Table 42. APAC Ertapenem Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Ertapenem Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Ertapenem Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Ertapenem Injection Sales by Type (2020-2025) & (K Units)
Table 46. Europe Ertapenem Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Ertapenem Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Ertapenem Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Ertapenem Injection Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Ertapenem Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Ertapenem Injection
Table 52. Key Market Challenges & Risks of Ertapenem Injection
Table 53. Key Industry Trends of Ertapenem Injection
Table 54. Ertapenem Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ertapenem Injection Distributors List
Table 57. Ertapenem Injection Customer List
Table 58. Global Ertapenem Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Ertapenem Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Ertapenem Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Ertapenem Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Ertapenem Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Ertapenem Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Ertapenem Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Ertapenem Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Ertapenem Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Ertapenem Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Ertapenem Injection Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Ertapenem Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Ertapenem Injection Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Ertapenem Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Ertapenem Injection Product Portfolios and Specifications
Table 74. Merck Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Endo Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Endo Ertapenem Injection Product Portfolios and Specifications
Table 79. Endo Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Endo Main Business
Table 81. Endo Latest Developments
Table 82. Aurobindo Pharma Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Aurobindo Pharma Ertapenem Injection Product Portfolios and Specifications
Table 84. Aurobindo Pharma Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Aurobindo Pharma Main Business
Table 86. Aurobindo Pharma Latest Developments
Table 87. ACS Dobfar Basic Information, Ertapenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. ACS Dobfar Ertapenem Injection Product Portfolios and Specifications
Table 89. ACS Dobfar Ertapenem Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. ACS Dobfar Main Business
Table 91. ACS Dobfar Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Ertapenem Injection
Figure 2. Ertapenem Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ertapenem Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Ertapenem Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Ertapenem Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Ertapenem Injection Sales Market Share by Country/Region (2024)
Figure 10. Ertapenem Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1g/Vial
Figure 12. Product Picture of Others
Figure 13. Global Ertapenem Injection Sales Market Share by Type in 2025
Figure 14. Global Ertapenem Injection Revenue Market Share by Type (2020-2025)
Figure 15. Ertapenem Injection Consumed in Adult
Figure 16. Global Ertapenem Injection Market: Adult (2020-2025) & (K Units)
Figure 17. Ertapenem Injection Consumed in Pediatric
Figure 18. Global Ertapenem Injection Market: Pediatric (2020-2025) & (K Units)
Figure 19. Global Ertapenem Injection Sale Market Share by Application (2024)
Figure 20. Global Ertapenem Injection Revenue Market Share by Application in 2025
Figure 21. Ertapenem Injection Sales by Company in 2025 (K Units)
Figure 22. Global Ertapenem Injection Sales Market Share by Company in 2025
Figure 23. Ertapenem Injection Revenue by Company in 2025 ($ millions)
Figure 24. Global Ertapenem Injection Revenue Market Share by Company in 2025
Figure 25. Global Ertapenem Injection Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Ertapenem Injection Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Ertapenem Injection Sales 2020-2025 (K Units)
Figure 28. Americas Ertapenem Injection Revenue 2020-2025 ($ millions)
Figure 29. APAC Ertapenem Injection Sales 2020-2025 (K Units)
Figure 30. APAC Ertapenem Injection Revenue 2020-2025 ($ millions)
Figure 31. Europe Ertapenem Injection Sales 2020-2025 (K Units)
Figure 32. Europe Ertapenem Injection Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Ertapenem Injection Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Ertapenem Injection Revenue 2020-2025 ($ millions)
Figure 35. Americas Ertapenem Injection Sales Market Share by Country in 2025
Figure 36. Americas Ertapenem Injection Revenue Market Share by Country (2020-2025)
Figure 37. Americas Ertapenem Injection Sales Market Share by Type (2020-2025)
Figure 38. Americas Ertapenem Injection Sales Market Share by Application (2020-2025)
Figure 39. United States Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Ertapenem Injection Sales Market Share by Region in 2025
Figure 44. APAC Ertapenem Injection Revenue Market Share by Region (2020-2025)
Figure 45. APAC Ertapenem Injection Sales Market Share by Type (2020-2025)
Figure 46. APAC Ertapenem Injection Sales Market Share by Application (2020-2025)
Figure 47. China Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. India Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Ertapenem Injection Sales Market Share by Country in 2025
Figure 55. Europe Ertapenem Injection Revenue Market Share by Country (2020-2025)
Figure 56. Europe Ertapenem Injection Sales Market Share by Type (2020-2025)
Figure 57. Europe Ertapenem Injection Sales Market Share by Application (2020-2025)
Figure 58. Germany Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 59. France Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Ertapenem Injection Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Ertapenem Injection Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Ertapenem Injection Sales Market Share by Application (2020-2025)
Figure 66. Egypt Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Ertapenem Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Ertapenem Injection in 2025
Figure 72. Manufacturing Process Analysis of Ertapenem Injection
Figure 73. Industry Chain Structure of Ertapenem Injection
Figure 74. Channels of Distribution
Figure 75. Global Ertapenem Injection Sales Market Forecast by Region (2026-2031)
Figure 76. Global Ertapenem Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Ertapenem Injection Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Ertapenem Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Ertapenem Injection Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Ertapenem Injection Revenue Market Share Forecast by Application (2026-2031)